Next Article in Journal
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases
Previous Article in Journal
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
 
 
Comment

Article Versions Notes

J. Clin. Med. 2020, 9(5), 1321; https://doi.org/10.3390/jcm9051321
Action Date Notes Link
article xml file uploaded 2 May 2020 14:02 CEST Original file -
article pdf uploaded. 2 May 2020 14:02 CEST Version of Record https://www.mdpi.com/2077-0383/9/5/1321/pdf-vor
article xml file uploaded 27 May 2020 11:01 CEST Update -
article xml uploaded. 27 May 2020 11:01 CEST Update -
article pdf uploaded. 27 May 2020 11:01 CEST Updated version of record https://www.mdpi.com/2077-0383/9/5/1321/pdf-vor
article html file updated 27 May 2020 11:03 CEST Original file -
article xml file uploaded 28 May 2020 14:25 CEST Update -
article xml uploaded. 28 May 2020 14:25 CEST Update https://www.mdpi.com/2077-0383/9/5/1321/xml
article pdf uploaded. 28 May 2020 14:25 CEST Updated version of record https://www.mdpi.com/2077-0383/9/5/1321/pdf
article html file updated 28 May 2020 14:27 CEST Update -
article html file updated 8 October 2020 23:27 CEST Update -
article html file updated 21 July 2022 03:45 CEST Update https://www.mdpi.com/2077-0383/9/5/1321/html
Back to TopTop